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Industrial bioprocesses place extraordinary demands on the metabolism of host cells to meet the biosynthetic 
requirements for maximal growth and protein production. Identifying host cell metabolic phenotypes that 
promote high recombinant protein titer is a major goal of the biotech industry. 13C metabolic flux analysis (MFA) 
provides a rigorous approach to quantify these metabolic phenotypes by applying stable isotope tracers to map 
the flow of carbon through intracellular metabolic pathways. We have conducted a series of 13C MFA studies to 
examine the metabolic impacts of altering the composition of a proprietary chemically defined growth medium 
on CHO cell metabolism.  
  
CHO cell cultures characteristically produce excess ammonia and lactate as byproducts, both of which are toxic 
at high concentrations. Whereas lactate is often consumed during stationary growth phase in CHO cell cultures, 
ammonia continues to accumulate in the extracellular media throughout the course of cell growth due mainly to 
glutamine catabolism. For CHO cells that utilize glutamine, rational media design can alleviate ammonia stress 
from the cell culture. However, manipulating carbon sources in the growth medium can also have negative 
effects on cellular metabolism such as decreased culture growth, viability, recombinant protein productivity, or 
longevity. This study highlights a rationally engineered cell culture medium that successfully reduces culture 
ammonia levels by 40% while maintaining the original metabolic phenotype.  
  
First, the basal media developed in-house by Sanofi was chemically altered to cause CHO cells to produce 
significantly less ammonia byproduct. This low ammonia-producing media variant was experimentally developed 
by altering the ratio of carbon sources in the media to strategically reduce flux through metabolic pathways that 
result in ammonia production while supplementing complementary, non-ammonia producing pathways to 
balance metabolism. This altered media variant successfully decreased the ammonia concentration in industrial 
CHO while maintaining culture growth, viability, and specific productivity.  
  
Parallel 13C MFA studies were performed on IgG-producing CHO cells grown identically in three media variants: 
the basal control media, the low-ammonia media, and the low-ammonia media supplemented with basal 
ammonia levels. The latter media was used to control for any direct effects of changing ammonia concentrations 
on cellular metabolism. 13C labeling studies utilizing [U-13C5]glutamine and [1,213C2]glucose were carried out in 
parallel for each condition. From the comparison of the 13C flux analysis across the three media types, we have 
concluded that the media alterations did not have a significant impact on the intracellular metabolism of CHO 
cultures. This suggests that Sanofi can use their newly developed media formulation to decrease toxic ammonia 
buildup in IgG-producing CHO cell lines without significantly altering host metabolic phenotype or productivity. 
 
